N115 Non-Steroidal COPD/Pulmonary Fibrosis Nasal Spray
Description
- Patented Rx Technology (6 Drug Patents)
- Drug Free, Non-Steroidal COPD/Pulmonary Fibrosis Nasal Spray that has shown to relieve clinical symptoms and improve lung functions, decrease coughing, and improve FEV-1, FVC, SaO2, and increase FEV-1/FVC ratios from 52% to 86% in all patients with Idiopathic Pulmonary Fibrosis (IPF).
- Completed US Phase I, Phase II, Phase III Clinical Trials for COPD Pulmonary Fibrosis/Interstitial Lung Disease.
- Submitted NDA to the FDA defining Medical Endpoint for the NDA Marketing Application.
- Received US FDA Orphan Drug Designation in 2005 for Cystic Fibrosis and Interstitial Lung Disease